-
Exclusive: Leading Biosciences Execs Talk About How The Company Could Save Hospitals Millions Of Dollars Per Year
Wednesday, April 19, 2017 - 8:09am | 1914Read More...Leading Biosciences is a small biopharmaceutical company focused on addressing the breakdown of the intestinal mucosal barrier using a simple technology platform. While privately held, this firm has been around for more than a decade. Benzinga met with CEO Tom Hallam, Ph.D., and Chief Financial...
-
Citigroup Says Actavis Is Now Worth $360 Per Share (And It's A Buy)
Wednesday, March 11, 2015 - 9:10am | 227Read More...In a report published Tuesday, Citigroup analyst Liav Abraham commented on a recent meeting with Actavis plc's (NYSE: ACT) senior management team in London that increased his confidence in a "swift and successful" integration of Allergan, Inc. Abraham noted that key growth...
